Bahrain vs Mali: Share of e coli bloodstream infections due to antimicrobial resistant
Bahrain
62.96
in 2022
Mali
60.87
in 2022
Bahrain rank
9th
Mali rank
10th
Share of e coli bloodstream infections due to antimicrobial resistant over time
- Bahrain
- Mali
How they compare
Bahrain currently reports 62.96 against 60.87 in Mali, a difference of 2.09.
The two have swapped places 2 times across 5 shared years of data; in 2018 it was Bahrain ahead.
Bahrain ranks 9th and Mali ranks 10th of 46 countries.
Bahrain has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 48.51 | 35.89 | 12.61 | Bahrain |
| 2020s | 59.94 | 56.02 | 3.92 | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e coli bloodstream infections due to antimicrobial resistant, Bahrain or Mali?
- Bahrain, at 62.96 against 60.87 in Mali as of 2022.
- What is the difference in share of e coli bloodstream infections due to antimicrobial resistant between Bahrain and Mali?
- 2.09, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Mali?
- 5 years are reported by both, from 2018 to 2022.
- How do Bahrain and Mali rank globally for share of e coli bloodstream infections due to antimicrobial resistant?
- Bahrain ranks 9th and Mali ranks 10th of 46 countries.
- Where does this data come from?
- Our World in Data, published as Share of e coli bloodstream infections due to antimicrobial resistant bacteria. Statizoid refreshes it automatically from the source and publishes the full history for both places.